Frontiers in Pharmacology | Respiratory Pharmacology

Original Research

Published on 22 Dec 2022

FGF10 ameliorates lipopolysaccharide-induced acute lung injury in mice via the BMP4-autophagy pathway

in Respiratory Pharmacology

Xiaoxia Kong
Liling Lu
Daopeng Lin
Lei Chong
Shunhang Wen
Yaokai Shi
Lidan Lin
Liqin Zhou
Hongyu Zhang
Hailin Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1019755

4,517 views
6 citations

Correction

Published on 16 Dec 2022

Corrigendum: Effect of M6A regulators on diagnosis, subtype classification, prognosis and novel therapeutic target development of idiopathic pulmonary fibrosis

in Respiratory Pharmacology

Guirui Huang
Shuaiyang Huang
Hongsheng Cui

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1117317

1,144 views

Review

Published on 12 Dec 2022

Emerging toolset of three-dimensional pulmonary cell culture models for simulating lung pathophysiology towards mechanistic elucidation and therapeutic treatment of SARS-COV-2 infection

in Respiratory Pharmacology

Kai Ni
Bo Che
Chongxin Yang
Youyuan Qin
Rong Gu
Chunhong Wang
Mingzhi Luo
Linhong Deng

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1033043

3,886 views
3 citations

Editorial

Published on 07 Dec 2022

Editorial: Antiviral drugs and vaccines against important human respiratory viruses

in Respiratory Pharmacology

Minghui Yang
Yang Yang
Qingbing Zheng
Khrustalev Vladislav Victorovich
Chenguang Shen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1082652

1,321 views

Correction

Published on 02 Dec 2022

Corrigendum: Danshensu methyl ester enhances autophagy to attenuate pulmonary fibrosis by targeting lncIAPF–HuR complex

in Respiratory Pharmacology

Qi Zhu
Jing Wang
Yunxia Ji
Jianlin Luan
Dayong Yue
Weili Liu
Hongbo Li
Jinjin Zhang
Guiwu Qu
Changjun Lv

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1086927

1,871 views

Review

Published on 02 Dec 2022

Human matters in asthma: Considering the microbiome in pulmonary health

in Respiratory Pharmacology

Sandesh J. Marathe
Mark A. Snider
Armando S. Flores-Torres
Patricia J. Dubin
Amali E. Samarasinghe

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1020133

7,229 views
8 citations

Original Research

Published on 29 Nov 2022

Inhaled platelet vesicle-decoyed biomimetic nanoparticles attenuate inflammatory lung injury

in Respiratory Pharmacology

Hua Jin
Renxing Luo
Jianing Li
Hongxia Zhao
Suidong Ouyang
Yinlian Yao
Dongyan Chen
Zijie Ling
Weicong Zhu
Meijun Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1050224

6,817 views
16 citations

Original Research

Published on 29 Nov 2022

Analysis of the safety and efficacy of different plasma concentrations of pirfenidone in patients with idiopathic pulmonary fibrosis

in Respiratory Pharmacology

Hui Li
Jing Yang
Shanshan Chen
Peile Wang
Xueqing Yu
Qingwei Zhou
Xiaojian Zhang
Guojun Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1055702

2,726 views
5 citations

Original Research

Published on 28 Nov 2022

Effect of M6A regulators on diagnosis, subtype classification, prognosis and novel therapeutic target development of idiopathic pulmonary fibrosis

in Respiratory Pharmacology

Guirui Huang
Shuaiyang Huang
Hongsheng Cui

Frontiers in Pharmacology

doi 10.3389/fphar.2022.993567

3,761 views
13 citations

Original Research

Published on 23 Nov 2022

Erythromycin attenuates oxidative stress-induced cellular senescence via the PI3K-mTOR signaling pathway in chronic obstructive pulmonary disease

in Respiratory Pharmacology

Yi Xiaofei
Li Tingting
Wei Xuan
He Zhiyi

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1043474

4,094 views
14 citations

Original Research

Published on 18 Nov 2022

Deficiency of endothelial FGFR1 alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice

in Respiratory Pharmacology

Yanrong Long
Hongbin Chen
Junchao Deng
Junjie Ning
Pengbo Yang
Lina Qiao
Zhongwei Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1039103

4,209 views
6 citations

Original Research

Published on 16 Nov 2022

Yangyinqingfei decoction attenuates PM2.5-induced lung injury by enhancing arachidonic acid metabolism

in Respiratory Pharmacology

Chunlan Tang
Yuqing Tang
Qinwen Wang
Donghui Chu
Jinyue Zhou
Yuping Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1056078

2,827 views
9 citations

Review

Published on 16 Nov 2022

The protective effect of natural medicines against excessive inflammation and oxidative stress in acute lung injury by regulating the Nrf2 signaling pathway

in Respiratory Pharmacology

Rumei Luan
Dongyan Ding
Junling Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1039022

4,429 views
27 citations

Review

Published on 15 Nov 2022

Senescent AECⅡ and the implication for idiopathic pulmonary fibrosis treatment

in Respiratory Pharmacology

Tingwei Zhang
Jinjin Zhang
Changjun Lv
Hongbo Li
Xiaodong Song

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1059434

7,137 views
15 citations

Original Research

Published on 11 Nov 2022

Fusion assays for screening of fusion inhibitors targeting SARS-CoV-2 entry and syncytia formation

in Respiratory Pharmacology

Shiu-Wan Chan

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1007527

6,042 views
9 citations

Editorial

Published on 07 Nov 2022

Editorial: Insights in respiratory pharmacology: 2021

in Respiratory Pharmacology

Paolo Montuschi
Irfan Rahman

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1052994

1,995 views